4026 Investors following Aventis Pharma. Share this News with them.
0
Like this story, share it with millions of investors on M3
Aventis Pharma Q1 PAT seen at Rs 36.3 cr: Motilal Oswal
Motilal Oswal has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, Aventis Pharma's June quarter sales are expected to go down by 6.3% to Rs 233.1 crore on YoY basis.
Motilal Oswal has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, Aventis Pharma 's June quarter sales are expected to go down by 6.3% to Rs 233.1 crore on YoY basis.
The company's adjusted PAT (profit after tax) is expected to go down by 13.2% to Rs 36.3 crore on YoY basis.